Kodiak Sciences Inc.
For the period ended Sep 30, 2025. Filed Nov 13, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 13, 2025
KOD$108.06+0.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Stockholders’ Equity
Condensed Consolidated Statem ents of Stockholders’ Equity (unaudited)
(in thousands, except share amounts)
| Common Stock · AdditionalPaid-In · Accumulated · TotalStockholders’ | |||||
|---|---|---|---|---|---|
| Shares | Amount | Capital | Deficit | Equity | |
| Balances at December 31, 2024 | 52,726,916 | $5 | $1,479,021 | $(1,328,738) | $150,288 |
| Exercise of stock options | 21,427 | — | 124 | — | 124 |
| Restricted stock units vested | 3,532 | — | — | — | — |
| Stock-based compensation | — | — | 15,891 | — | 15,891 |
| Net loss | — | — | — | (57,461) | (57,461) |
| Balances at March 31, 2025 | 52,751,875 | 5 | 1,495,036 | (1,386,199) | 108,842 |
| Exercise of stock options | 15,320 | — | 38 | — | 38 |
| Restricted stock units vested | 26,061 | — | — | — | — |
| Proceeds from ESPP | 28,433 | — | 82 | — | 82 |
| Stock-based compensation | — | — | 15,641 | — | 15,641 |
| Net loss | — | — | — | (54,313) | (54,313) |
| Balances at June 30, 2025 | 52,821,689 | 5 | 1,510,797 | (1,440,512) | 70,290 |
| Exercise of stock options | 168,413 | — | 813 | — | 813 |
| Restricted stock units vested | 8,459 | — | — | — | — |
| Stock-based compensation | — | — | 14,046 | — | 14,046 |
| Net loss | — | — | — | (61,457) | (61,457) |
| Balances at September 30, 2025 | 52,998,561 | $5 | $1,525,656 | $(1,501,969) | $23,692 |
| Common Stock · AdditionalPaid-In · Accumulated · TotalStockholders’ | |||||
| Shares | Amount | Capital | Deficit | Equity | |
| Balances at December 31, 2023 | 52,508,602 | $5 | $1,418,307 | $(1,152,531) | $265,781 |
| Exercise of stock options | 8,333 | — | 38 | — | 38 |
| Restricted stock units vested | 6,512 | — | — | — | — |
| Stock-based compensation | — | — | 18,409 | — | 18,409 |
| Net loss | — | — | — | (43,039) | (43,039) |
| Balances at March 31, 2024 | 52,523,447 | 5 | 1,436,754 | (1,195,570) | 241,189 |
| Restricted stock units vested | 64,476 | — | — | — | — |
| Proceeds from ESPP | 26,806 | — | 59 | — | 59 |
| Stock-based compensation | — | — | 18,375 | — | 18,375 |
| Net loss | — | — | — | (45,117) | (45,117) |
| Balances at June 30, 2024 | 52,614,729 | 5 | 1,455,188 | (1,240,687) | 214,506 |
| Exercise of stock options | — | — | — | — | — |
| Restricted stock units vested | 8,358 | — | — | — | — |
| Stock-based compensation | — | — | 14,810 | — | 14,810 |
| Net loss | — | — | — | (43,946) | (43,946) |
| Balances at September 30, 2024 | 52,623,087 | $5 | $1,469,998 | $(1,284,633) | $185,370 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.